Adar Poonawalla

Timelines
Adar Poonawalla, WHO scientist warn of delays in vaccine production

05 Mar 2021

Adar Poonawalla, WHO scientist warn of delays in vaccine production

Adar Poonawalla, the head of the world's biggest vaccine maker, and the World Health Organization's (WHO) chief scientist have said that the manufacturers of coronavirus vaccine doses are facing a global shortage of the raw materials required to produce the doses.

After SII fire, BCG, rotavirus vaccine production to be hit

22 Jan 2021

After SII fire, BCG, rotavirus vaccine production to be hit

Thursday's fire at Pune's Serum Institute of India will impact the production of BCG and rotavirus vaccines in the future, the company said on Friday.

Five killed in Serum Institute fire; Maharashtra government orders probe

21 Jan 2021

Five killed in Serum Institute fire; Maharashtra government orders probe

The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.

Pune: Fire breaks out at Serum Institute of India

21 Jan 2021

Pune: Fire breaks out at Serum Institute of India

On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.

Rs. 200 per vaccine dose: SII receives government's purchase order

11 Jan 2021

Rs. 200 per vaccine dose: SII receives government's purchase order

The Pune-based Serum Institute of India (SII) has received the purchase order for COVID-19 vaccines from the central government, officials said on Monday.

Coronavirus vaccine consignment awaits government nod for take-off from Pune

08 Jan 2021

Coronavirus vaccine consignment awaits government nod for take-off from Pune

On Thursday night, the Pune Airport was prepared to airlift vials of coronavirus vaccine, the first such exercise in India's massive inoculation drive.

Sleeves up! Coronavirus vaccination drive could begin on January 13

05 Jan 2021

Sleeves up! Coronavirus vaccination drive could begin on January 13

The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

05 Jan 2021

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

Private hospitals may get coronavirus vaccine by March: Serum CEO

04 Jan 2021

Private hospitals may get coronavirus vaccine by March: Serum CEO

While the Indian government has prioritized healthcare workers and high-risk individuals in its vaccine program, doses of the coronavirus vaccine will be available for private companies, hospitals, and individuals by as early as March, the CEO of Serum Institute of India (SII), Adar Poonawalla, said on Sunday.

'Finally paid off,' says Adar Poonawalla after Covishield gets approval

03 Jan 2021

'Finally paid off,' says Adar Poonawalla after Covishield gets approval

Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.

All you need to know about vaccines approved in India

03 Jan 2021

All you need to know about vaccines approved in India

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

India set to start COVID-19 vaccination; panel approves Oxford vaccine

01 Jan 2021

India set to start COVID-19 vaccination; panel approves Oxford vaccine

In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.

Centre extends COVID-19 surveillance guidelines till January 31

28 Dec 2020

Centre extends COVID-19 surveillance guidelines till January 31

The Ministry of Home Affairs on Monday extended guidelines for COVID-19 surveillance, containment, and caution till January 31, 2021.

Modi to chair all-party meet to review COVID-19 situation Friday

30 Nov 2020

Modi to chair all-party meet to review COVID-19 situation Friday

Prime Minister Narendra Modi is set to chair an all-party meeting this Friday to review the COVID-19 situation in India, according to reports.

Applying for Covishield's emergency approval in 2 weeks: SII

28 Nov 2020

Applying for Covishield's emergency approval in 2 weeks: SII

The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.

PM to visit three cities to review coronavirus vaccine development

28 Nov 2020

PM to visit three cities to review coronavirus vaccine development

Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.

Can launch 100 million vaccine doses by January-February, says Poonawalla

23 Nov 2020

Can launch 100 million vaccine doses by January-February, says Poonawalla

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

Oxford vaccine to be available by April 2021 in India

20 Nov 2020

Oxford vaccine to be available by April 2021 in India

Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to seek an emergency approval from the government of India next month, for providing the coronavirus vaccine to "corona warriors" and the elderly.

India to get 10cr COVID-19 vaccine doses by December: SII

14 Nov 2020

India to get 10cr COVID-19 vaccine doses by December: SII

The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.

COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR

12 Nov 2020

COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR

The Indian Council of Medical Research (ICMR) and Pune-based Serum Institute of India (SII) on Thursday announced the completion of enrollment of participants to the Phase-3 clinical trials for the potential COVID-19 vaccine COVISHIELD in India.

Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

08 Nov 2020

Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

Bharat Biotech's coronavirus vaccine could be out by February 2021

05 Nov 2020

Bharat Biotech's coronavirus vaccine could be out by February 2021

The coronavirus vaccine being developed by Bharat Biotech could be launched by February, months earlier than expected, an official from the Indian Council of Medical Research (ICMR), told Reuters on Thursday.

Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

05 Nov 2020

Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

Vaccine tracker: Covishield expected by December; Moderna readies for launch

01 Nov 2020

Vaccine tracker: Covishield expected by December; Moderna readies for launch

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.

Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

29 Oct 2020

Oxford's coronavirus vaccine could be available by December: Adar Poonawalla

In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.

Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country

22 Oct 2020

Coronavirus: India reserves Rs. 50,000 crore for vaccinating entire country

The Indian government has reportedly set aside Rs. 50,000 crore to ensure that the COVID-19 vaccine reaches the entire country.

India to play crucial role in COVID-19 vaccine process

20 Oct 2020

India to play crucial role in COVID-19 vaccine process

As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.

PM's vaccine arrangements will take care of all: Adar Poonawalla

27 Sep 2020

PM's vaccine arrangements will take care of all: Adar Poonawalla

As India's COVID-19 vaccine strategy becomes a point of debate, Adar Poonawalla has expressed confidence over Prime Minister Narendra Modi's vision to protect Indian citizens from the ongoing pandemic.

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

16 Sep 2020

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.

NewsBytes Briefing: Potential signs of life on Venus, and more

15 Sep 2020

NewsBytes Briefing: Potential signs of life on Venus, and more

Last night, our planetary neighbor Venus made major headlines as a group of researchers found potential signs of alien life using ground-based telescopes.

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

14 Sep 2020

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.

Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute

30 Aug 2020

Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute

One of Bangladesh's largest drugmakers, Beximco Pharmaceuticals, has announced that it will invest in the Serum Institute of India (SII) for the development of a coronavirus vaccine.

India: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials

19 Aug 2020

India: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials

In a major development, Adar Poonawalla's Serum Institute of India has started the Phase-2/3 trial of a promising COVID-19 vaccine licensed from AstraZeneca and Oxford University.

Australia secures 'promising' COVID-19 vaccine, will offer it for free

19 Aug 2020

Australia secures 'promising' COVID-19 vaccine, will offer it for free

In a bid to exit the COVID-19 pandemic for good, Australia has secured access to a "promising vaccine."

Three indigenous coronavirus vaccines in trials, distribution plan ready: PM

15 Aug 2020

Three indigenous coronavirus vaccines in trials, distribution plan ready: PM

With the world counting on a coronavirus vaccine to save it from the disease that has taken 763,572 lives so far, Prime Minister Narendra Modi on Saturday said India is ready to mass-produce the vaccine once it's developed.

India likely to have COVID-19 vaccine by December: Adar Poonawalla

11 Aug 2020

India likely to have COVID-19 vaccine by December: Adar Poonawalla

India should have a vaccine to exit the COVID-19 pandemic by the end of this year.

NewsBytes Briefing: William English, computer mouse co-inventor, dies at 91

03 Aug 2020

NewsBytes Briefing: William English, computer mouse co-inventor, dies at 91

A lot has happened over the weekend.

Coronavirus: How much would the vaccines cost?

30 Jul 2020

Coronavirus: How much would the vaccines cost?

As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.

Oxford's COVID-19 vaccine: India readies five sites for human trials

28 Jul 2020

Oxford's COVID-19 vaccine: India readies five sites for human trials

India has prepared five sites for the final human trials phase of the potential COVID-19 vaccine developed by Oxford University, reports PTI.

How soon could there be a vaccine for COVID-19?

25 Jul 2020

How soon could there be a vaccine for COVID-19?

Since the coronavirus outbreak started late last year, researchers have been racing to develop a vaccine against the virus, SARS-CoV-2.